Impact of COVID-19 on neurological patients attending a botulinum toxin service.

Roberto ErroSara ScannapiecoMaria RussoMarina PicilloPaolo Barone

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)

Keyphrases

botulinum toxin
end stage renal disease
coronavirus disease
sars cov
chronic kidney disease
ejection fraction
healthcare
newly diagnosed
mental health
prognostic factors